Eppendorf: Culture of 3D Cell Aggregates in Perfusion
July 11, 2018 @ 10:00 am - 11:00 am EDT
Three-dimensional (3D) cell aggregates are of great interest for many applications, including disease modeling, drug toxicity assessment, and manufacture of stem cell-based products. Stirred-tank bioreactors are promising culture systems for 3D cell aggregates, as they allow efficient establishment and maintenance of cell aggregates, process monitoring and control, and process scale-up to larger volumes. Furthermore, they can be operated in perfusion mode, which allows 3D cell aggregates to be sustained longer than in traditional batch cultures.
This webcast will review a research example for process development with the human tumor cell line H157, cultivated in stirred-tank mini bioreactors as 3D cell aggregates.
Learn about the challenges and benefits of perfusion cultivation for stem cells and 3D cell models
Gain insight on the impact of impeller geometry on cell growth and aggregate formation
Interact with an expert in a live Q&A session
North America | Europe Broadcasts: Wednesday, July 11, 2018 at 10am EDT | 9am CDT | 3pm BST | 4pm CESTAsia Pacific Broadcast: Wednesday, July 11, 2018 at 11:30am IST | 2pm CST | 3pm JST
Speaker: Dr. Philipp Nold, Infield Application Specialist, Eppendorf Bioprocess Center, Juelich, Germany
This webcast will review a research example for process development with the human tumor cell line H157, cultivated in stirred-tank mini bioreactors as 3D cell aggregates.